Track Medtech Start-ups

Learn More
innovation hub

Vital Therapies (NASDAQ:VTL) is Profiled in this Database

Updated At 17 Mar, 2014

Start Free 7 Day Trial Now
Partial description of this company
Cell-based therapy targeting the treatment of acute liver failure

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Vital Therapies (NASDAQ:VTL) plus 4781 other startups.

Start Free 7 Day Trial Now

Learn More About Vital Therapies (NASDAQ:VTL)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Our Clients